Cargando…

Cholangiocarcinoma

Liver cancer represents the third leading cause of cancer-related death worldwide. Cholangiocarcinoma (CCA) is the second most common type of liver cancer after hepatocellular carcinoma, accounting for 10-15% of all primary liver malignancies. Both the incidence and mortality of CCA have been steadi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarcognato, Samantha, Sacchi, Diana, Fassan, Matteo, Fabris, Luca, Cadamuro, Massimiliano, Zanus, Giacomo, Cataldo, Ivana, Capelli, Paola, Baciorri, Francesca, Cacciatore, Matilde, Guido, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore srl 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299326/ https://www.ncbi.nlm.nih.gov/pubmed/34294934 http://dx.doi.org/10.32074/1591-951X-252

Ejemplares similares

Benign biliary neoplasms and biliary tumor precursors
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Pathology of non-alcoholic fatty liver disease
por: Cataldo, Ivana, et al.
Publicado: (2021)

Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma
por: Cadamuro, Massimiliano, et al.
Publicado: (2022)

Necroptosis in Cholangiocarcinoma
por: Sarcognato, Samantha, et al.
Publicado: (2020)

Ferroptosis in Intrahepatic Cholangiocarcinoma: IDH1(105GGT) Single Nucleotide Polymorphism Is Associated With Its Activation and Better Prognosis
por: Sarcognato, Samantha, et al.
Publicado: (2022)

Pathology of autoimmune hepatitis
por: Covelli, Claudia, et al.
Publicado: (2021)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma
por: Cadamuro, Massimiliano, et al.
Publicado: (2023)

Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?
por: Brivio, Simone, et al.
Publicado: (2015)

Fetal Lung Interstitial Tumor (FLIT): Review of The Literature
por: Perin, Silvia, et al.
Publicado: (2023)

Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma
por: Cadamuro, Massimiliano, et al.
Publicado: (2017)

Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness
por: Brivio, Simone, et al.
Publicado: (2017)

Hepatocellular carcinoma: a clinical and pathological overview
por: Renne, Salvatore Lorenzo, et al.
Publicado: (2021)

Case Report: An early-onset inflammatory colitis due to a variant in TNFAIP3 causing A20 haploinsufficiency
por: Zanatta, Laura, et al.
Publicado: (2022)

FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice
por: Angerilli, Valentina, et al.
Publicado: (2023)

Histopathology of the temporomandibular joint disc: Findings in 30 samples from joints with degenerative disease
por: Guarda Nardini, Luca, et al.
Publicado: (2021)

Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the “Reactive” Biliary Epithelial Phenotype
por: Fabris, Luca, et al.
Publicado: (2016)

New insights on the role of vascular endothelial growth factor in biliary pathophysiology
por: Mariotti, Valeria, et al.
Publicado: (2021)

Bile Duct Lithiasis Mimicking a Perihilar Cholangiocarcinoma—An Endless Dilemma: A Case Report
por: Piccino, Marco, et al.
Publicado: (2023)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
por: Simbolo, Michele, et al.
Publicado: (2014)

The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored
por: Gambella, Alessandro, et al.
Publicado: (2023)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation
por: Morton, Stuart Duncan, et al.
Publicado: (2015)

Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
por: Gkountakos, Anastasios, et al.
Publicado: (2023)

Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma
por: Simbolo, Michele, et al.
Publicado: (2018)

Treatment of Combined Hepatocellular and Cholangiocarcinoma
por: Leoni, Simona, et al.
Publicado: (2020)

Current Perspectives in Liver Transplantation for Perihilar Cholangiocarcinoma
por: Giovinazzo, Francesco, et al.
Publicado: (2023)

Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy
por: Scimeca, Manuel, et al.
Publicado: (2023)

Gut inflammation and tumorigenesis: every site has a different tale to tell
por: Vanoli, Alessandro, et al.
Publicado: (2023)

The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases
por: Cadamuro, Massimiliano, et al.
Publicado: (2020)

Neuroendocrine neoplasms of the esophagus and stomach
por: Mastracci, Luca, et al.
Publicado: (2021)

Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
por: Simile, Maria Maddalena, et al.
Publicado: (2019)

Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats
por: Gabbia, Daniela, et al.
Publicado: (2020)

The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome
por: Melchionna, Roberta, et al.
Publicado: (2016)

Inflammatory and tumor-like lesions of the pancreas
por: Luchini, Claudio, et al.
Publicado: (2020)

Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials
por: Tovoli, Francesco, et al.
Publicado: (2021)

Sleep Treatments in Disorders of Consciousness: A Systematic Review
por: Cacciatore, Martina, et al.
Publicado: (2021)

Heterogeneity of Cholangiocarcinoma Immune Biology
por: Vita, Francesca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hmd1bc1se4oh29k4lf7df595s1